Skip to content
PeptideGeek

Healing & recovery

Apelin-13, explained simply

A natural heart hormone that helps your cardiovascular system work better and supports healthy blood flow throughout your body.

Some human studiesIV infusion (clinical settings)7 cited sourcesResearch compound — not FDA approved

Start here

What is Apelin-13?

Apelin-13 is one of the most active forms of apelin, a hormone the body makes to help the heart and blood vessels work properly. Discovered in 1998, it supports heart muscle strength, blood pressure control, and fluid balance, and researchers are studying it for heart failure. It has reached early human trials (Phase 1-2) but remains a research compound, not an approved medicine.

How it works in your body

Apelin-13 is a hormone your body makes that helps control blood pressure, heart strength, and fluid balance. It works by docking onto a landing site on cells called the APJ receptor, found in the heart and blood vessels. That signal helps the heart squeeze more strongly and keeps extra fluid from building up, which is why researchers are studying it for heart failure 47.

The deeper mechanism, for the curious

Apelin-13 is the 13-amino acid tail end of apelin. It switches on the APJ receptor, a G-protein coupled receptor (a type of docking site on the cell surface). 57 Switching on APJ makes the heart contract more strongly, widens blood vessels, and makes blood vessel walls less leaky. In heart failure models, apelin signaling improves heart function and reduces hypertrophy (thickening of the heart muscle). 7

Evidence check

Some human studies

It has been tested in people, but only in small or early-stage studies. Promising, but not yet proven the way an approved medicine is.

Every numbered marker on this page links to one of the 7 sources at the bottom.

82/100

Cardiovascular Support

Helps maintain normal blood pressure and cardiovascular function

78/100

Heart Function & Strength

Supports healthy heart muscle contraction and strength

74/100

Blood Flow & Circulation

Promotes healthy blood vessel formation and blood flow

What the research points to

  • Supports healthy heart muscle contraction and strength
  • Helps maintain normal blood pressure and cardiovascular function
  • Promotes healthy blood vessel formation and blood flow
  • May help protect heart tissue from damage during stress
  • Supports the body's natural ability to regulate fluid balance
  • May help reduce harmful inflammation in the heart

The most-asked question

How much Apelin-13 do I take?

The research-reported range is 100 nmol/min, once daily. Studies used different doses for different situations — find yours:

  1. Heart failure research, Cardiovascular studies

    30 nmol/min

    • How often
      Steady drip
    • For how long
      5 minutes per dose step (research setting)
    • How
      Injection into a vein (IV)

    Apelin-13 is a research peptide given as a short drip into a vein in studies, not by self-injection. This low rate was the first step tested in a human heart study. 4

  2. Heart failure research, Cardiovascular studies

    100 nmol/min

    • How often
      Steady drip
    • For how long
      5 minutes per dose step (research setting)
    • How
      Injection into a vein (IV)

    Middle infusion rate used in the human heart study. It increased the heart's output and relaxed blood vessels. 4

  3. Heart failure research, Cardiovascular studies

    300 nmol/min

    • How often
      Steady drip
    • For how long
      5 minutes per dose step (research setting)
    • How
      Injection into a vein (IV)

    Highest infusion rate tested in the same human study, producing the strongest effect on heart output and blood pressure. 4

Adjusting your dose

You're at the right dose if…

  • Therapeutic goals being met with minimal side effects
  • Stable and consistent response to treatment
  • Lab values or clinical markers trending in the right direction
  • Good tolerance with manageable or absent side effects

Consider going up if…

  • You've tolerated the current dose for the recommended period without significant side effects
  • Therapeutic goals haven't been met at the current dose level
  • Your healthcare provider recommends dose escalation based on your response
  • Lab work or clinical assessments support a higher dose

Go down if…

  • Side effects are bothersome or impacting daily life despite management strategies
  • You experience any signs of an adverse reaction
  • Lab results indicate the need for dose reduction
  • Your healthcare provider recommends a lower dose based on your response

The ceiling: As prescribed (as determined by your healthcare provider based on individual response and tolerance)

Reconstitution, in plain words

How do I mix Apelin-13?

Peptides usually arrive as a freeze-dried powder in a small vial. “Reconstitution” just means adding sterile water back in so you can measure a dose. Here's how it works for Apelin-13:

What you need

  • Apelin-13 vial (lyophilized powder or solution)
  • Bacteriostatic water or sterile sodium chloride for reconstitution
  • Alcohol swabs for cleaning vial tops and injection sites
  • Appropriately sized syringes with fine-gauge needles (27-30 gauge)
  • Sharps disposal container

A worked example

Add the recommended volume of bacteriostatic water to the Apelin-13 vial. Gently swirl (do not shake) until the powder is fully dissolved. The resulting solution should be clear. Calculate your individual dose based on the concentration and your prescribed amount.

Working out your dose

Your dose of Apelin-13 is determined by your healthcare provider. Using an insulin syringe marked in units, draw up the exact amount prescribed. For example, if the reconstituted concentration is 1mg/mL and your dose is 0.5mg, draw up 0.5mL (50 units on an insulin syringe). Always double-check calculations before injection.

Or let the calculator do it

Three quick questions — your vial, your water, your dose — and it tells you the exact syringe mark. “Find dose amount” is preloaded with Apelin-13's recorded schedule.

Apelin-13Steady drip

How much peptide is in your bottle?

Look at the label on the vial. It’s the number next to the unit — like "5 mg". Labeled in IU? Switch the unit to IU.

Type a number to continue.
0

Injection sites & technique

Where do I inject Apelin-13?

The best spots

  • Abdomen (stomach area)—at least 2 inches from the belly button, most popular choice for self-injection
  • Front of thighs—middle to upper portion of the outer leg
  • Back of upper arm—outer area (may need assistance from another person)

How to do it, step by step

  • Wash your hands thoroughly with soap and water before handling supplies
  • Clean the injection site with an alcohol swab and let it air dry completely
  • Pinch a fold of skin at the chosen injection site
  • Insert the needle at a 45-90 degree angle (depending on needle length and body composition)
  • Inject the medication slowly and steadily over 5-10 seconds
  • Release the skin fold and remove the needle, applying gentle pressure with a clean swab
  • Rotate injection sites to prevent tissue irritation or lumpy fat changes under the skin (lipodystrophy (lumpy or dented fat under the skin at injection sites))
  • Dispose of the needle safely in a sharps container—never recap or reuse needles

Subcutaneous (under the skin) injection (into the fatty tissue just under the skin)—allows for consistent absorption and can be self-administered at home after proper training

Timing

When do I take Apelin-13?

Best time of day

Apelin-13 is administered intravenously in a clinical setting. 4 Timing is determined by your healthcare provider based on the treatment protocol and your medical needs.

With or without food?

IV administration of Apelin-13 is not dependent on meal timing. Your healthcare team will provide specific instructions regarding food and fluid intake around treatment sessions.

Taking it with other peptides

Apelin-13 should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.

The honest list

What side effects could Apelin-13 cause?

Common — usually mild

These show up most often. They usually fade as your body adjusts.

  • Mild changes in blood pressure

    Mild changes in blood pressure

    What to do Consult your healthcare provider for guidance.

  • Minimal systemic effects in animal studies

    Minimal systemic (affecting the whole body) effects in animal studies

    What to do Consult your healthcare provider for guidance.

  • Headache (theoretical, based on blood pressure effects)

    Headache (theoretical, based on blood pressure effects)

    What to do Consult your healthcare provider for guidance.

  • Flushing or warmth at injection site

    Flushing or warmth at injection site

    What to do Consult your healthcare provider for guidance.

  • Mild inflammation at injection site

    Mild inflammation at injection site

    What to do Consult your healthcare provider for guidance.

  • Dizziness if blood pressure drops too quickly

    Dizziness if blood pressure drops too quickly

    What to do Consult your healthcare provider for guidance.

  • Allergic reactions to the peptide

    Allergic reactions to the peptide

    What to do Consult your healthcare provider for guidance.

  • Heart rhythm changes (requires monitoring)

    Heart rhythm changes (requires monitoring)

    What to do Consult your healthcare provider for guidance.

  • Blood pressure, heart rate, and how well the heart works

    Blood pressure, heart rate, cardiac function

    What to do Consult your healthcare provider for guidance.

Serious — stop and get medical help

Rare, but if any of these happen, stop and contact a medical professional.

  • Severe allergic reaction

    In rare cases, Apelin-13 may trigger a severe allergic reaction including difficulty breathing, facial swelling, or widespread rash. This requires immediate medical attention.

    What to do STOP treatment immediately and seek emergency medical care. Do not restart without medical clearance. Report all allergic reactions to your healthcare provider.

Week by week

What should I expect from Apelin-13, and when?

  1. Minutes (Immediate)

    You might notice
    • Heart rate and blood pressure begin to change
    • Apelin-13 starts switching on the APJ receptor (a docking spot on heart and blood vessel cells)
    • The heart starts to pump more forcefully
    What's normal
    • Initial response to Apelin-13 is beginning at the cellular level
    • Different individuals experience Apelin-13's onset at different rates
    • Transient systemic (affecting the whole body) effects from initial Apelin-13 exposure are common
    What's next
    • Maintain consistent Apelin-13 administration as prescribed
    • Document subjective effects and physical markers daily
    • Schedule a check-in with your provider about initial observations

  2. Hours (Short-term)

    You might notice
    • Blood vessels relax most strongly
    • Blood flow improves throughout the body
    • Anti-inflammatory effects begin
    What's normal
    • Apelin-13 is attaching to its targets on cells (receptors) well enough to work
    • Its main effect is taking hold
    • Early short-lived effects are fading
    What's next
    • Maintain consistent Apelin-13 administration as prescribed
    • Document subjective effects and physical markers daily
    • Schedule a check-in with your provider about initial observations

  3. Days to Weeks (Repeated Dosing)

    You might notice
    • Adaptive cardiovascular responses;
    • improved heart muscle function with regular use;
    • potential protective effects building up
    What's normal
    • Apelin-13 response patterns are emerging
    • Initial Apelin-13 response is consistent with mechanism expectations
    • Early tolerance development to Apelin-13 is not expected
    What's next
    • Assess whether Apelin-13 response aligns with expectations
    • Plan next steps based on initial Apelin-13 tolerance and response
    • Establish baseline monitoring for Apelin-13 response tracking

How to tell it's actually working

Treatment Response

  • Improvement in the primary symptoms or condition being treated
  • Positive changes in relevant lab values or clinical markers
  • Consistent, stable response to Apelin-13 over time
  • Reduction in symptom frequency or severity

General Well-being

  • Improved energy levels and daily functioning
  • Better quality of life related to the treated condition
  • Manageable or absent side effects indicating good tolerance
  • Positive feedback from healthcare provider during check-ups

Not seeing anything? The usual reasons

  • Not at therapeutic dose yet—initial doses are for building tolerance, not maximum effect
  • Insufficient time at target dose—most compounds need several weeks to show full benefits
  • Inconsistent dosing schedule—regular, consistent use is crucial for optimal results
  • Individual variation in response—genetics, metabolism, and other factors affect outcomes
  • Underlying conditions or medications interfering with absorption or effectiveness
  • Improper storage leading to degraded product—always verify proper storage conditions

Is it right for you?

Who should avoid Apelin-13?

Do not use it if…

  • Currently under investigation - not for human clinical use
  • May interact with blood pressure medications (in theory)
  • Should not be used if allergic to peptides or component amino acids
  • Pregnant or breastfeeding individuals should avoid

Be extra careful if…

  • You are taking other medications—discuss potential interactions with your healthcare provider
  • You have a history of liver or kidney disease
  • You are elderly or have multiple medical conditions
  • You are planning surgery in the near future—inform your surgeon about Apelin-13 use
  • You have any chronic health conditions that require regular monitoring

When to stop

  • Severe or worsening side effects that don't improve with dose adjustment or supportive care
  • Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
  • Your healthcare provider recommends discontinuation based on your clinical response
  • Development of any new medical condition that may be contraindicated with Apelin-13
  • Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
  • Abnormal lab results or clinical markers that suggest adverse effects

Apelin-13 should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.

What it mixes badly (and well) with

Medications

  • Avoid
    Other heart-active peptides without proper spacing and monitoring

    Use with caution—discuss with your healthcare provider.

  • Avoid
    ACE inhibitors or ARBs (blood pressure medication - requires careful monitoring)

    Use with caution—discuss with your healthcare provider.

  • Avoid
    Stimulant compounds that raise heart rate significantly

    Use with caution—discuss with your healthcare provider.

Other peptides

  • OK together
    APJ receptor agonist research compounds

    May be used together under medical guidance.

  • OK together
    Studies on angiotensin II regulation (cardiovascular balance)

    May be used together under medical guidance.

  • OK together
    Mitochondrial health research (heart energy production)

    May be used together under medical guidance.

Supplements

  • OK together
    Multivitamins

    Generally safe to take alongside Apelin-13. Space doses apart if taking oral formulations to ensure optimal absorption.

  • OK together
    Electrolyte supplements

    Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.

Who it tends to suit

Research into cardiovascular health and heart function

Apelin-13 is particularly well-suited for individuals focused on research into cardiovascular health and heart function. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach 47.

Understanding how the body naturally protects the heart

Apelin-13 is particularly well-suited for individuals focused on understanding how the body naturally protects the heart. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach 3.

Exploring potential treatments for heart failure

Apelin-13 is particularly well-suited for individuals focused on exploring potential treatments for heart failure. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach 47.

Studying mechanisms of heart muscle strength

Apelin-13 is particularly well-suited for individuals focused on studying mechanisms of heart muscle strength. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach 4.

The safety picture overall

Apelin-13 is a research compound with no human clinical trials and no FDA approval. All safety data come from animal studies and lab work on cells showing helpful effects on blood vessels and heart structure. But animal results do not predict human safety, and the peptide's effects on the human immune system are untested. No studies exist on human dosing, how the body processes it, or whether it builds up in organs. Its target (the APJ receptor) sits on many tissues, including the brain, raising concerns about unintended effects on the nervous system at high doses.

The evidence is entirely animal studies in mice, rats, and larger mammals, plus lab work on how the peptide binds its target and affects blood vessels. No human studies exist: nothing on how the body processes it, no toxicity screening, no Phase 1 safety studies, no trials of whether it works. The research explains how it might work rather than showing it is safe.

Keeping it good

How do I store Apelin-13?

Before mixing (powder)

Store Apelin-13 in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.

After mixing (liquid)

Once reconstituted, Apelin-13 should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.

Signs it has gone bad

  • Solution appears cloudy, discolored, or contains visible particles (should be clear)
  • Product has been exposed to temperatures outside the recommended storage range
  • Product has been frozen (unless specifically designed for freeze-thaw stability)
  • Expiration date has passed or reconstituted solution has exceeded its use-by date
  • Unusual odor, color change, or visible contamination

Not our opinion — the published record

What the studies actually found about Apelin-13

2025

Exogenous [Pyr(1)]apelin-13 prevents bupivacaine-induced cardiotoxicity via the apelin (APJ) receptor

Apelin-13 at 22 μmol/L completely reversed the heart poisoning caused by bupivacaine (a local anesthetic) in both cell and animal models. It improved heart cell function and raised survival from 50% to 100%. The peptide protected the structure of mitochondria (the cell's power plants) and improved survival through its interaction with the APJ receptor (a docking site on cells).

Chen C, Zhao S, Chen Z

2025

A Metabolically Stable Apelin-13 Analog Acting as a Potent I(To) Potassium Current Blocker with Potential Benefits for Brugada Syndrome

A modified version of apelin-13 selectively blocked the ITO potassium current (a flow of charged potassium particles in heart cells) by 47%. This lengthened the heart cell's electrical signal (action potential) without affecting sodium currents. This targeted blocking restores the electrical balance that is disrupted in Brugada syndrome (an inherited heart rhythm disorder).

Contreras Vite JA, Tiffinger A, Théroux L

2010

Acute cardiovascular effects of apelin in humans: potential role in patients with chronic heart failure

In healthy people and heart failure patients, [Pyr1]apelin-13 was given by IV drip (into a vein) at 30, 100 and 300 nmol/min (each for 5 minutes). It raised cardiac index (how much blood the heart pumps for body size) and lowered mean arterial pressure (average blood pressure) and peripheral vascular resistance (how hard it is for blood to flow through the body's small vessels).

Japp AG, Cruden NL, Barnes G, et al.

2026

International Union of Basic and Clinical Pharmacology. CXXI. Apelin receptor pharmacology in the human cardiovascular system and emerging clinical applications

The IUPHAR review of how drugs act on the apelin receptor (IUPHAR is the international pharmacology society). When [Pyr1]apelin-13 was infused into healthy volunteers, it raised cardiac output (the amount of blood the heart pumps) and lowered peripheral resistance (how hard it is for blood to flow through small vessels), without side effects. These effects held in people with heart failure and pulmonary arterial hypertension (high blood pressure in the lung arteries). The review covers the receptor's structure, the apelin peptide family, and drugs in development. No approved apelin medicine exists yet.

Davenport AP, Williams TL, Nyimanu D, et al.

If this isn't the right fit

What people use instead of Apelin-13

Alternative approaches for healing & recovery support

  • Consult your healthcare provider for alternatives to Apelin-13 based on your specific needs and medical history

Alternative healing peptides

  • BPC-157
  • TB-500 (Thymosin Beta-4)
  • GHK-Cu

Non-peptide recovery options

  • Platelet-Rich Plasma (PRP)
  • Collagen supplements
  • Physical therapy

Your questions

Apelin-13 FAQ

What does Apelin-13 do in your body?

Apelin-13 is a natural hormone that makes your heart stronger and helps your blood flow better. It sends messages to your heart cells telling them to pump more efficiently and helps your blood vessels relax so blood can move through them more easily. It's like a natural boost for your cardiovascular system 47.

Is Apelin-13 approved by the FDA?

No, not yet. Apelin-13 is still in the research stage. Scientists are studying it in laboratories and on animals to understand how it works and how safe it is. It's not available as a medicine for people to use outside of approved clinical research studies 7.

How is Apelin-13 different from Apelin-36?

Apelin-13 and Apelin-36 are different lengths of the same peptide. Apelin-13 is shorter and often works faster and is easier for the body to use. Apelin-36 is longer and might stay active in your body longer. Both switch on the APJ receptor (their docking site on cells), but scientists often prefer studying Apelin-13 because it's more manageable to work with 57.

What is the APJ receptor (the docking site on cells that apelin attaches to)?

The APJ receptor is like a lock on your heart cells that apelin-13 is the key for. When apelin-13 binds to APJ receptors, it starts a chain of events inside the cell that improves heart function. This receptor was discovered in 1993, but scientists didn't find its natural key (apelin) until 1998 56.

Could Apelin-13 help with heart disease?

That's the big question scientists are investigating right now. Early studies show promise that apelin-13 could help protect damaged hearts and improve heart function. However, much more research is needed before it can be used to treat people with heart disease. Several research teams are working on modified versions of apelin-13 that might be safer and more effective for patients 47.

7 sources

References

Every numbered marker on this page points to one of these. Same sources, same numbering as the Apelin-13 research profile on Peptide Initiative.

  1. Exogenous [Pyr(1)]apelin-13 prevents bupivacaine-induced cardiotoxicity via the apelin (APJ) receptorChen C, Zhao S, Chen Z · 2025
  2. A Metabolically Stable Apelin-13 Analog Acting as a Potent I(To) Potassium Current Blocker with Potential Benefits for Brugada SyndromeContreras Vite JA, Tiffinger A, Théroux L · 2025
  3. Apelin/APJ signaling in IGF-1-induced acute mitochondrial and antioxidant effects in spontaneously hypertensive rat myocardiumYeves AM, Godoy Coto J, Pereyra EV · 2024
  4. Acute cardiovascular effects of apelin in humans: potential role in patients with chronic heart failureJapp AG, Cruden NL, Barnes G, et al. · 2010
  5. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptorTatemoto K, Hosoya M, Habata Y, et al. · 1998
  6. A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11O'Dowd BF, Heiber M, Chan A, et al. · 1993
  7. International Union of Basic and Clinical Pharmacology. CXXI. Apelin receptor pharmacology in the human cardiovascular system and emerging clinical applicationsDavenport AP, Williams TL, Nyimanu D, et al. · 2026

Want the deep science?

Read the full Apelin-13 research profile

Every claim on this page traces back to the research database behind Peptide Initiative — studies, citations, clinical trial data, and the technical detail we deliberately left out here.

Open the research profile

More healing & recovery guides

This guide is education, not medical advice. Apelin-13 is a research compound that is not FDA-approved for human use. Talk to a clinician before taking anything.